What does FDA require drug manufacturers to do to prevent contaminated drugs? If contamination occurs, how must they correct the problem?
To prevent contamination and ensure product quality, FDA requires companies to follow Current Good Manufacturing Practice regulations (CGMPs) for manufacturing drugs. If contamination is discovered during production of a drug, manufacturers must not distribute the product and must correct the problem, using a “corrective action plan.” Sometimes, however, contamination is discovered after distribution. If this occurs, FDA expects manufacturers to recall affected batches, investigate, and take measures to prevent it from happening again. When a batch is recalled, FDA:
- Asks the company to stop shipping and to recall product that has already been shipped;
- May take samples for analysis to find the contamination's source and may also use the company's production records to find out the extent of how much product could be involved;
- Conducts a health hazard evaluation (HHE) to determine how the public might be affected;
- Works with the company to issue public notices and recall alerts;
- Oversees the company’s corrective action plan, which can include re-inspection by FDA and contacting distributors and retailers to ensure product is recalled.
FDA cannot order a firm to recall a drug. If a company will not cooperate with a recall or investigation, FDA can take regulatory action. If FDA finds contamination because the manufacturer did not follow CGMPs, FDA may take enforcement action that can include issuing warning letters, seizing product, obtaining court orders to prevent further manufacturing, or even criminal fines and jail time. FDA may also request a state regulatory body to take action.
- Where can I find information about adverse reactions to a medicine prescribed for my child?
- Where can I find information about medicines prescribed for my child?
- Materials from Webinar on Access to Investigational Drugs
- FDA Basics Webinar: "Mini-Sentinel," FDA's New Tool for Monitoring the Safety of FDA-Approved Medical Products
- How FDA Evaluates Regulated Products: Drugs
- FDA Webinar on Prescription Drug Shortages
- FDA Webinar on "Bad Ads" Program
- FDA Basics Webinar on Generic Drugs
- FDA Basics Videos: Tim Coté on Orphan Drugs
- What is an FDA Drug Safety Communication?
- What is counterfeit medicine?
- FDA Basic Video: Interview with John Jenkins on New Drugs (Video)
- What are unapproved drugs and why are they on the market?
- How can I stay better informed about drugs? Is there a reliable website FDA recommends?
- How do I discard medicine that I no longer need, do I just throw it in the garbage?
- How do I report a bad reaction to medicine or medication error to FDA?
- Does FDA approve the proprietary names of prescription drugs?
- What does FDA require drug manufacturers to do to prevent contaminated drugs? If contamination occurs, how must they correct the problem?
- How does FDA help consumers when drug shortages happen?
- Does FDA approve the information given out by pharmacies when I pick up my medicine?
- How does FDA decide when a drug is not safe enough to stay on the market?
- How do I find out if a drug is approved? Is there a Web site I can go to?
- What is the approval process for a new prescription drug?
- What is a Warning Letter?
- Can FDA ban direct-to-consumer drug advertising?
How helpful was this information?